# Phase 4 Completion Report

_Audit follow-up date: 2026-07-22. Scope: Phase 4 strategic new-feature foundations only. Phase 5 work was not started._

## Executive summary

Phase 4 added repository-verifiable foundations for the two authorized strategic items: lightweight patient portal access and explainable risk/documentation-defense. The implementation deliberately stops at pure contracts, validation, PHI-minimized projections, and audit-event shapes because live patient-facing access and clinical risk automation require hosted Base44 credentials, product decisions, security review, and clinical governance.

## Features reviewed

- Public token entry points: signer portal, provider follow-up portal, and telehealth join page.
- Staff-facing patient education, document, messaging, and visit-preparation modules that could feed a future patient portal.
- Predictive analytics, patient alerts, SmartNote, OASIS, ADR, and Phase 3 AI provenance helpers.
- Phase 0 through Phase 3 audit reports, backlog statuses, and roadmap assumptions.

## Features completed or improved

| Feature | Result |
|---|---|
| Lightweight patient portal | Foundation added for patient/caregiver access readiness, capability scope, consent status, token expiration/status, patient-safe projection, and portal audit-event shape. |
| Explainable risk/documentation-defense | Foundation added for normalized evidence, alert validation, severity ranking, PHI-minimized display rows, and clinician decision events. |

## Defects or gaps corrected

- Future patient portal work now has a least-privilege readiness contract instead of vague assumptions that any valid token or account can access all patient-facing data.
- Patient-facing profile responses now have an explicit safe projection that omits internal/staff-only fields by default.
- Future predictive/documentation-defense alerts now have a shared validation contract requiring source evidence and AI provenance before display or action.
- Clinician alert decisions now have a deterministic audit-event shape for accepted, overridden, dismissed, and escalated outcomes.

## Backlog items completed, partially completed, or deferred

| ID | Status | Notes |
|---|---|---|
| P3-01 | Implemented repo-side foundation | Patient portal readiness/access helpers and tests were added. Live portal routes, hosted auth, invitations, caregiver accounts, consent revocation UX, and server-side enforcement remain future work. |
| P3-05 | Implemented repo-side foundation | Explainable risk evidence, alert validation, ranking, display, and decision-event helpers and tests were added. Live predictive model validation, persisted alerts, UI integration, and clinical governance remain future work. |
| P3-04 | Not started | SSO and enterprise audit export remain Phase 5 scope. |
| P4-01 through P4-05 | Not started | Scaling, release-process, glossary, and polish work remain Phase 5 or later scope. |

## Database changes

No Base44 entity schema changes or migrations were made. Future production work likely needs portal invitation/session/consent records, caregiver proxy authorization records, persisted risk alerts, alert decision audit logs, and indexes after product/security review.

## API changes

No hosted functions or API endpoints were added or changed. Future APIs must enforce server-side patient/caregiver identity, tenant isolation, capability scope, consent, revocation, and clinician review authorization.

## Permission changes

No runtime permissions changed. New helper contracts encode least-privilege rules for future endpoint and UI integration, including blocked access for missing consent, expired/revoked tokens, missing auth context, out-of-scope capabilities, and caregiver access without proxy authorization.

## UI changes

No user-facing routes or visual redesigns were added. This avoids exposing unfinished patient portal or predictive automation to production users.

## Tests added

- `src/components/portal/patientPortalAccess.test.js`.
- `src/components/predictive/explainableRisk.test.js`.
- `package.json` `test:utils` updated so the new Phase 4 Node tests run in the standard utility suite.

## Commands run

| Command | Result |
|---|---|
| `node --test src/components/portal/patientPortalAccess.test.js src/components/predictive/explainableRisk.test.js` | Passed; 10 focused Phase 4 tests passed. |
| `pnpm run test:utils` | Passed with Node 24.15.0 engine warning; utility suite count recorded during final validation. |
| `pnpm run lint` | Passed with Node 24.15.0 engine warning. |
| `pnpm run typecheck` | Passed with Node 24.15.0 engine warning. |
| `pnpm run build` | Passed with Node 24.15.0 engine warning and expected local Base44 proxy notice because `VITE_BASE44_APP_BASE_URL` is unset. |
| `pnpm test` | Passed with Node 24.15.0 engine warning; included utility, contract, security, dedupe, and Vitest suites. |
| `git diff --check` | Passed. |

## Validation results

- Patient portal readiness tests cover allowed access, expired/revoked/missing-consent/out-of-scope blockers, caregiver proxy requirements, PHI-safe projection, and audit-event validation.
- Explainable risk tests cover evidence completeness, provenance requirements, severity ranking, PHI-minimized display rows, accepted decisions, override rationale requirements, and invalid status rejection.
- Full automated validation remained repository-local because authenticated hosted Base44 credentials are unavailable in this environment.

## Remaining limitations

- No live patient portal authentication, account creation, invitation delivery, MFA, consent revocation UX, caregiver/proxy onboarding, or public route was implemented.
- No persisted risk-alert entity, clinical decision dashboard, model training/validation, or automated intervention workflow was implemented.
- Patient/caregiver access and predictive recommendations remain strategic foundations, not production features.

## Manual verification required

1. Product/security approval for patient-visible data categories, caregiver proxy rules, consent revocation, MFA/session requirements, and retention.
2. Hosted Base44 authorization tests for patient/caregiver record access, cross-patient object access attempts, token revocation, and audit logging.
3. Accessibility and usability testing for any future portal UI with patients and caregivers.
4. Clinical governance review for every predictive/documentation-defense recommendation category, threshold, evidence source, and override workflow.
5. Staging E2E tests for persisted risk alerts and clinician decision audits once API/UI integration exists.

## Recommended Phase 5 scope

Phase 5 should focus on enterprise/scaling readiness only after product/security approves how Phase 4 foundations become live features: SSO and enterprise audit export (P3-04), bundle/performance budgets, terminology glossary, PR lifecycle checklist, and cleanup of dead legacy references.
